Dmitri Wiederschain
Keine laufenden Positionen mehr
Profil
Dmitri Wiederschain worked as the Chief Scientific Officer at Jounce Therapeutics, Inc. and as the VP & Global Head-Immuno Oncology Research at Sanofi.
He received his undergraduate and doctorate degrees from Harvard University.
Ehemalige bekannte Positionen von Dmitri Wiederschain
| Unternehmen | Position | Ende |
|---|---|---|
| SANOFI | Corporate Officer/Principal | - |
| JOUNCE THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Dmitri Wiederschain
| Harvard University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SANOFI | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Jounce Therapeutics, Inc.
 Jounce Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Jounce Therapeutics, Inc. is a clinical stage immunotherapy company, which engages in developing treatments for cancer. It also provides novel cancer immunotherapies to attack tumors. The company was founded by Louis M. Weiner, Drew M. Pardoll, Thomas F. Gajewski, James P. Allison, Robert Schreiber, and Padmanee Sharma in 2013 and is headquartered in Cambridge, MA. | Commercial Services |